Home
Perceptive Life Sciences Master Fund, 10% Owner: Acrivon Therapeutics ACRV Sell · Filed 25/05/01
Trade details
- Type
- Insider sale
- Amount
- $617,412.21
- Shares · price
- 437,881 sh · $1.41 a share
- Held after
- 3,403,025 sh
- Trade date
- 25/04/30
- Filed
- 25/05/01
- Days to filing
- 1 days
Sold 11.4% of holdings
- Share of holding sold
- 11.4%
Acrivon Therapeutics trades, last 26 weeks
What else happened in Acrivon Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/31~25/05/30Perceptive Life Sciences Master Fund's recent trades
- Perceptive Life Sciences Master Fund
SellLyra Therapeutics
SellLyra Therapeutics
LYRA
$111.5K
28,597 sh
$111.5K
Filed 25/11/13
Traded 25/11/13
- Perceptive Life Sciences Master Fund
SellLyra Therapeutics
SellLyra Therapeutics
LYRA
$31.9K
7,862 sh
$31.9K
Filed 25/11/13
Traded 25/11/12
- Perceptive Life Sciences Master Fund
SellLyra Therapeutics
SellLyra Therapeutics
LYRA
$20.6K
4,783 sh
$20.6K
Filed 25/11/13
Traded 25/11/11
- Perceptive Life Sciences Master Fund
SellLyra Therapeutics
SellLyra Therapeutics
LYRA
$12.5K
3,213 sh
$12.5K
Filed 25/11/13
Traded 25/11/13
- Perceptive Life Sciences Master Fund
SellLyra Therapeutics
SellLyra Therapeutics
LYRA
$3,585
883 sh
$3,585
Filed 25/11/13
Traded 25/11/12